longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Mirum Pharmaceuticals

MIRM

87.5400.48% ( -0.420 )
Closed: Sep 29, 16:00:00 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -6.61, above the reasonable range, cheaper than 2.05% of the time in the past 3 years, and the industry ranks 403/603, the industry Median -2.26.

-6.61xP/E
$87.54Stock price
$-13.25Earnings per share
-6.61xP/E
Stock price$87.54Earnings per share$-13.25

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-18.83x
Typical range
-63.08x–-7.52x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
019385776

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
GILDUSGilead Sciences
-57.90x148.77%$187.58B
MRNAUSModerna
-25.78x15.47%$81.23B
CSLLYUSCSL Limited
-23.70x--$61.13B
NTRAUSNatera
-310.64x8.22%$59.75B
RVMDUSRevolution Medicines
-24.79x63.01%$43.83B
ROIVUSRoivant Sciences
-99.02x146.49%$26.36B
INSMUSInsmed
-28.85x74.61%$25.25B
BNTXUSBioNTech SE
-12.65x17.57%$24.76B
SMMTUSSummit Therapeutics
-15.27x19.83%$13.08B
BBIOUSBridgebio Pharma
-18.64x28.48%$12.90B
TWSTUSTwist Bioscience
-89.63x20.00%$12.25B
MDGLUSMadrigal Pharma
-36.21x51.06%$11.77B
IBRXUSImmunityBio
-9.43x152.63%$9.36B
ARWRUSArrowHead Pharma
-29.25x36,308.30%$9.36B
KYMRUSKymera Therapeutics
-30.67x4.94%$9.19B
CYTKUSCytokinetics
-10.21x6.37%$9.13B
ABVXUSAbivax SA
-18.44x22.49%$8.59B
PCVXUSVaxcyte
-7.93x48.80%$8.44B
PRAXUSPraxis Precision Medicines
-23.13x3.05%$7.85B
IONSUSIonis Pharma
-13.49x50.60%$7.63B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.